Elwyn Glyn, Iredale Rachel, Gray Jonathon
Department of General Practice, University of Wales College of Medicine, Llanedeyrn Health Centre, Cardiff, UK.
Fam Pract. 2002 Feb;19(1):65-71. doi: 10.1093/fampra/19.1.65.
The demand for genetic services is increasing as public awareness about 'predictive' tests increases and commercial marketing initiatives develop. In the UK, genetic services vary widely between regions. To manage demand, an all-Wales cancer genetics service based on telephone triage and referral guidelines was designed and implemented.
The aim of this study was to examine the reactions of GPs to a cancer genetics service controlled by referral guidelines and a triage system, and the perceived impact genetics will have on general practice.
We conducted a structured qualitative study in primary care using sequential focus group discussions with 14 GPs, representing 12 practices divided into two groups (service providers and educationalists). The doctors were introduced to the 'new' genetics, briefed about the service and the referral guidelines and given an outline of the topics to be discussed. All discussions were recorded, transcribed and analysed.
The GPs in this study had not considered how they and their teams would handle the practical implications of the 'new' genetics. They had no major objections to a triage system as a means of regulating access to a scarce specialist service, but were concerned about two issues. First, that an insistence on the completion of a postal questionnaire as a means of obtaining an initial assessment could disadvantage some individuals and, secondly, that it was not clear to either the GP or the patient that the risk assessment would be undertaken by a telephone interview. Although there was some concern about yet another set of referral guidelines, participants accepted that the potential demand for cancer genetics services had to be regulated.
The acceptance by GPs of this triage system represented a reluctant acknowledgement that primary care, in its present organizational form, cannot provide high quality genetic counselling. However, the realization that this represented a relinquishment of the normal generalist role led to the emergence of ambivalence and a wish to consider how best to accommodate this new need in primary care.
随着公众对“预测性”检测的认识提高以及商业营销活动的开展,对基因服务的需求不断增加。在英国,各地区的基因服务差异很大。为了管理需求,设计并实施了一项基于电话分诊和转诊指南的全威尔士癌症基因服务。
本研究的目的是调查全科医生对由转诊指南和分诊系统控制的癌症基因服务的反应,以及基因检测对全科医疗的预期影响。
我们在初级医疗保健机构进行了一项结构化定性研究,通过与14名全科医生进行连续的焦点小组讨论,这些医生代表12个诊所,分为两组(服务提供者和教育工作者)。向医生介绍了“新”基因检测,简要说明了服务内容和转诊指南,并概述了要讨论的主题。所有讨论都进行了记录、转录和分析。
本研究中的全科医生尚未考虑他们及其团队将如何应对“新”基因检测的实际影响。他们对分诊系统作为一种调节获得稀缺专科服务途径的手段没有重大异议,但关注两个问题。第一,坚持要求填写邮政问卷作为获得初步评估的手段可能对一些人不利;第二,全科医生和患者都不清楚风险评估将通过电话访谈进行。尽管对另一套转诊指南存在一些担忧,但参与者承认必须对癌症基因服务的潜在需求进行管理。
全科医生对这种分诊系统的接受代表了一种不情愿的承认,即目前组织形式的初级医疗保健无法提供高质量的基因咨询。然而,意识到这意味着放弃正常的全科医生角色导致了矛盾情绪的出现,并希望考虑如何在初级医疗保健中最好地满足这一新需求。